Effects of canagliflozin on the glycemic control and plasma GLP-1 levels.
Phase of Trial: Phase II
Latest Information Update: 20 Sep 2016
At a glance
- Drugs Canagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 06 Sep 2016 Status changed from active, no longer recruiting to completed.
- 20 Jul 2016 Status changed from recruiting to active, no longer recruiting.
- 21 Aug 2015 New trial record